Table of Contents
ISRN Obstetrics and Gynecology
Volume 2013, Article ID 120735, 4 pages
http://dx.doi.org/10.1155/2013/120735
Clinical Study

Ritodrine Should Be Carefully Administered during Antenatal Glucocorticoid Therapy Even in Nondiabetic Pregnancies

1Perinatal Medical Center, Tokyo Women’s Medical University Hospital, Kawadacho 8-1, Shinjuku, Tokyo 162-8666, Japan
2Department of Obstetrics and Gynecology, Tokyo Women’s Medical University, Tokyo, Japan

Received 19 January 2013; Accepted 12 February 2013

Academic Editors: M. Friedrich, N. A. Ginsberg, and K. Yang

Copyright © 2013 Masaki Ogawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. C. Liggins and R. N. Howie, “A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants,” Pediatrics, vol. 50, no. 4, pp. 515–525, 1972. View at Google Scholar · View at Scopus
  2. U.S. Department of Health and Human Services, “Report on the consensus development conference on the effect of corticosteroids for fetal maturation on perinatal outcomes,” Tech. Rep. NIH Pub No. 95-3784, Public Health Service, 1994. View at Google Scholar
  3. “Committee Opinion No. 475: antenatal corticosteroid therapy for fetal maturation,” Obstetrics & Gynecology, vol. 117, pp. 422–424, 2011.
  4. RCOG Guidelines. Number 7, ACS to prevent respiratory distress syndrome. London: RCOG, 1996.
  5. J. E. Fisher, R. S. Smith, R. Lagrandeur, and R. P. Lorenz, “Gestational diabetes mellitus in women receiving beta-adrenergics and corticosteroids for threatened preterm delivery,” Obstetrics and Gynecology, vol. 90, no. 6, pp. 880–883, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Bedalov and A. Balasubramanyam, “Glucocorticoid-induced ketoacidosis in gestational diabetes: Sequela of the acute treatment of preterm labor. A case report,” Diabetes Care, vol. 20, no. 6, pp. 922–924, 1997. View at Google Scholar · View at Scopus
  7. J. Star, J. Hogan, M. E. Sosa, and M. W. Carpenter, “Glucocorticoid-associated maternal hyperglycemia: a randomized trial of insulin prophylaxis,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 9, pp. 273–277, 2000. View at Google Scholar
  8. A. Schumacher, J. Sidor, and K. J. Bühling, “Continuous glucose monitoring using the glucose sensor CGMS® during betamethasone therapy in non-diabetic pregnant women,” Zeitschrift fur Geburtshilfe und Neonatologie, vol. 210, no. 5, pp. 184–190, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. C. G. Hatjis, L. H. Nelson, P. J. Meis, and M. Swain, “Addition of magnesium sulfate improves effectiveness of ritodrine in preventing premature delivery,” American Journal of Obstetrics and Gynecology, vol. 150, no. 2, pp. 142–150, 1984. View at Google Scholar · View at Scopus
  10. D. Roberts and S. Dalziel, “Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth,” Cochrane Database of Systematic Reviews, vol. 3, p. CD004454, 2006. View at Google Scholar · View at Scopus
  11. J. S. Refuerzo, A. Garg, B. Rech, S. M. Ramin, A. Vidaeff, and S. C. Blackwell, “Continuous glucose monitoring in diabetic women following antenatal corticosteroid therapy: a pilot study,” American Journal of Perinatology, vol. 29, pp. 335–338, 2012. View at Google Scholar
  12. M. B. Schneider, G. E. Umpierrez, R. D. Ramsey, W. C. Mabie, and K. A. Bennett, “Pregnancy complicated by diabetic ketoacidosis: maternal and fetal outcomes,” Diabetes Care, vol. 26, no. 3, pp. 958–959, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Bouhanick, F. Biquard, S. Hadjadj, and M. A. Roques, “Does treatment with antenatal glucocorticoids for the risk of premature delivery contribute to ketoacidosis in pregnant women with diabetes who receive continuous subcutaneous insulin infusion (CSII)?” Archives of Internal Medicine, vol. 160, no. 2, pp. 242–243, 2000. View at Google Scholar · View at Scopus
  14. I. M. Bernstein and P. M. Catalano, “Ketoacidosis in pregnancy associated with the parenteral administration of terbutaline and betamethasone. A case report,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 35, no. 8, pp. 818–820, 1990. View at Google Scholar · View at Scopus
  15. M. T. Cullen, E. A. Reece, C. J. Homko, and E. Sivan, “The changing presentations of diabetic ketoacidosis during pregnancy,” American Journal of Perinatology, vol. 13, no. 7, pp. 449–451, 1996. View at Google Scholar · View at Scopus